Cresset Asset Management, LLC Abb Vie Inc. Transaction History

Cresset Asset Management, LLC

$20.6 Billion
Q1 2024

A detailed history of Cresset Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 290,583 shares of ABBV stock, worth $48.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

290,583

Previous 211,223 37.57%

Holding current value

$48.2 Million

Previous $32.7 Million 61.66%

% of portfolio

0.26%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $12.7 Million - $14.5 Million	79,360 Added 37.57%	290,583 $52.9 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $2.19 Million - $2.47 Million	-15,907 Reduced 7.0%	211,223 $32.7 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.95 Million - $2.26 Million	14,611 Added 6.88%	227,130 $33.9 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $20.9 Million - $26 Million	157,748 Added 288.01%	212,519 $28.6 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $902,077 - $1.04 Million	-6,238 Reduced 10.22%	54,771 $8.73 Million

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $677,165 - $812,099	4,896 Added 8.73%	61,009 $9.87 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $596,966 - $684,680	-4,448 Reduced 7.34%	56,113 $7.53 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $333,040 - $423,403	2,420 Added 4.16%	60,561 $9.07 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $3.04 Million - $3.78 Million	-23,066 Reduced 28.4%	58,141 $9.43 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $3.03 Million - $3.83 Million	28,185 Added 53.16%	81,207 $11 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $932,170 - $1.06 Million	8,761 Added 19.79%	53,022 $5.72 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $663,349 - $739,009	6,305 Added 16.61%	44,261 $4.99 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $882,030 - $971,009	8,622 Added 29.39%	37,956 $4.11 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $301,998 - $407,729	-3,752 Reduced 11.34%	29,334 $3.14 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $75,600 - $88,730	-880 Reduced 2.59%	33,086 $2.9 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $2.55 Million - $3.41 Million	-34,773 Reduced 50.59%	33,966 $3.34 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $865,783 - $1.31 Million	-13,423 Reduced 16.34%	68,739 $5.24 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $1.73 Million - $2.16 Million	-23,988 Reduced 22.6%	82,162 $7.28 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $2.95 Million - $3.55 Million	-46,898 Reduced 30.64%	106,150 $8.04 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $2.03 Million - $2.59 Million	30,896 Added 25.29%	153,048 $11.1 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $8.37 Million - $9.85 Million	108,461 Added 792.21%	122,152 $2.04 Million
Q4 2018 May 21, 2019	BUY	$77.85 - $96.01 $1.07 Million - $1.31 Million	13,691 New	13,691 $1.26 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Abb Vie Inc. Transaction History